Current Edition

Current Features

Advertisement

Current Edition

Volume 16 Issue 2

PCI Discusses Annex 1 Complaint Expansion Plans for Sterile Fill-Finish and Lyophilization 

Forward-thinking life sciences organisations have switched on to the benefits of AI-powered automation, to transform their research and development operations and st...
Continue Reading →
Volume 16 Issue 2

AI & Automation: How Advanced is Adoption in Life Sciences R&D?  

Forward-thinking life sciences organisations have switched on to the benefits of AI-powered automation, to transform their research and development operations and st...
Continue Reading →
Volume 16 Issue 2

Alleviating Regulatory Burden Through Access Consortium 

While regulatory authorities are in- creasingly adopting reliance programs to assess applications, few offer the opportunity to take advantage of simultaneous assess...
Continue Reading →
Volume 16 Issue 2

Integrating Medical Devices into Pharmacovigilance Portfolios   

How to Navigate the Latest EU Medical Device Regulatory Landscape to Successfully Adapt your Pharma Portfolio Understanding medical device regulations is essentia...
Continue Reading →
Volume 16 Issue 2

The Oncology Crux – Asking the Smart Oncology Questions Before Shaping an Asset’s Journey to Market   

With over 2,000 oncology clinical trials currently ongoing, the speed at which the market is evolving makes it increasingly difficult for pharmaceutical companies to...
Continue Reading →
Volume 16 Issue 2

Engaging Minority Communities: Collaborative Practises and Long-Term Success  

The quest to understand and treat rare diseases poses unique challenges. Rare diseases, often referred to as orphan diseases, affect a small percentage of the popula...
Continue Reading →

Company Profiles